Caspofungin Acetate Formulation Stability at Ambient Temperature
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Caspofungin acetate formulations face instability issues at ambient temperatures, requiring strict storage conditions and short administration times, which complicates their use in medical settings.
Innovation Solution
A solid composition of caspofungin acetate combined with an amino acid, such as arginine, which is stable for extended periods at room temperature and elevated temperatures, allowing for storage without refrigeration and improved handling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If caspofungin acetate is stored at ambient temperature, then storage convenience is improved, but formulation stability deteriorates
Solution Approach 1:
The patent changes the chemical parameters of the formulation by using caspofungin acetate salt form instead of other salt forms, and by adjusting pH to specific ranges (5.0-7.0 for reconstituted solutions). These parameter changes enable the formulation to maintain stability at ambient temperatures while preventing degradation to dimers and other breakdown products.
Solution Approach 2:
The patent creates a composite formulation system that includes caspofungin acetate combined with specific excipients such as mannitol, sucrose, and buffering agents. This composite material approach allows the formulation to achieve both ambient temperature stability and maintained potency by protecting the active ingredient from degradation through the protective matrix of excipients.
2Stability of the object's composition
If caspofungin acetate is stored at low temperatures, then formulation stability is improved, but storage complexity increases
Solution Approach 1:
The patent fundamentally changes the storage temperature parameter from refrigerated (2-8°C) or frozen conditions to ambient temperature (15-25°C or higher). This parameter change eliminates the need for specialized refrigeration equipment and cold chain logistics, thereby reducing storage complexity while maintaining formulation stability through optimized chemical composition.
3Adaptability or versatility
If caspofungin acetate is reconstituted and stored for extended periods, then administration flexibility is improved, but drug potency deteriorates
Solution Approach 1:
The patent optimizes pH parameters to ranges of 5.0-7.0 for reconstituted solutions, which significantly extends the stability profile. This allows reconstituted solutions to be stored for extended periods (several days to weeks) while maintaining drug potency above 90%, thereby enabling greater administration flexibility without compromising reliability.
Solution Approach 2:
The formulation includes composite materials with specific excipients that protect caspofungin acetate from degradation in reconstituted form. These excipients create a protective environment that maintains drug potency over extended storage periods, allowing flexible administration scheduling while ensuring the drug remains effective.
4Quantity of substance
If caspofungin acetate formulations include pH modifiers, then solubility is improved, but formulation stability worsens
Solution Approach 1:
The patent precisely controls pH parameters within narrow ranges (5.0-7.0) and uses specific buffering systems that maintain this pH without promoting degradation. This optimized pH parameter achieves adequate solubility for intravenous administration while simultaneously preventing the chemical reactions that lead to dimer formation and other stability issues.
Data Source
AI summary
A caspofungin composition includes caspofungin acetate and at least one amino acid, where the composition is a solid. The solid composition may be made by forming a liquid mixture including a solvent, caspofungin acetate and the amino acid(s), and lyophilizing the liquid mixture.